Neogen Chemicals Ltd: Share Price Analysis, Intrinsic Value & Fundamentals (2025)

Share Price and Basic Stock Data

Last Updated: March 8, 2025, 11:16 am

Market Cap	4,758 Cr.
Current Price	1,804
High / Low	2,420/1,149
Stock P/E	80.1
Book Value	298
Dividend Yield	0.11 %
ROCE	10.4 %
ROE	7.06 %
Face Value	10.0
PEG Ratio	7.41

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Neogen Chemicals Ltd

Competitors of Neogen Chemicals Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
HP Adhesives Ltd	431 Cr.	47.0	115/42.6	22.3	19.2	0.64 %	17.7 %	12.6 %	2.00
Haryana Leather Chemicals Ltd	38.3 Cr.	78.0	124/56.8	9.30	87.2	1.28 %	8.96 %	7.25 %	10.0
Hardcastle & Waud Mfg Co Ltd	48.3 Cr.	710	1,355/563	27.6	663	0.00 %	7.00 %	5.98 %	10.0
Grauer & Weil (India) Ltd	4,145 Cr.	91.4	120/72.2	25.8	19.2	0.55 %	26.1 %	19.6 %	1.00
DMCC Speciality Chemicals Ltd	765 Cr.	298	453/245	36.7	85.4	0.34 %	7.55 %	2.89 %	10.0
Industry Average	11,704.46 Cr	733.10		47.54	173.82	0.38%	13.99%	10.73%	6.44

All Competitor Stocks of Neogen Chemicals Ltd

Quarterly Result

Metric	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Sales	133	157	148	148	186	204	170	168	164	191	167	193	200
Expenses	109	130	123	124	156	171	141	142	143	157	138	157	163
Operating Profit	24	27	25	24	30	33	29	26	22	34	28	36	38
OPM %	18%	17%	17%	16%	16%	16%	17%	16%	13%	18%	17%	19%	19%
Other Income	0	1	1	0	1	2	2	2	2	4	3	2	2
Interest	6	5	6	7	7	9	11	11	11	9	9	12	13
Depreciation	4	4	4	4	4	4	5	5	6	5	6	7	7
Profit before tax	14	19	16	14	21	21	16	12	7	23	17	20	20
Tax %	24%	17%	29%	29%	29%	31%	28%	26%	69%	24%	25%	25%	28%
Net Profit	10	16	11	10	15	14	11	9	2	18	12	15	14
EPS in Rs	4.49	6.28	4.46	3.97	5.90	5.75	4.58	3.66	0.85	6.71	4.71	5.63	5.46

Last Updated: February 28, 2025, 6:11 pm

Below is a detailed analysis of the quarterly data for Neogen Chemicals Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

For Sales, as of Dec 2024, the value is ₹200.00 Cr.. The value appears strong and on an upward trend. It has increased from 193.00 Cr. (Sep 2024) to ₹200.00 Cr., marking an increase of ₹7.00 Cr..
For Expenses, as of Dec 2024, the value is ₹163.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 157.00 Cr. (Sep 2024) to ₹163.00 Cr., marking an increase of ₹6.00 Cr..
For Operating Profit, as of Dec 2024, the value is ₹38.00 Cr.. The value appears strong and on an upward trend. It has increased from 36.00 Cr. (Sep 2024) to ₹38.00 Cr., marking an increase of ₹2.00 Cr..
For OPM %, as of Dec 2024, the value is 19.00%. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 19.00%.
For Other Income, as of Dec 2024, the value is ₹2.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 2.00 Cr..
For Interest, as of Dec 2024, the value is ₹13.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 12.00 Cr. (Sep 2024) to ₹13.00 Cr., marking an increase of ₹1.00 Cr..
For Depreciation, as of Dec 2024, the value is ₹7.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 7.00 Cr..
For Profit before tax, as of Dec 2024, the value is ₹20.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 20.00 Cr..
For Tax %, as of Dec 2024, the value is 28.00%. The value appears to be increasing, which may not be favorable. It has increased from 25.00% (Sep 2024) to 28.00%, marking an increase of 3.00%.
For Net Profit, as of Dec 2024, the value is ₹14.00 Cr.. The value appears to be declining and may need further review. It has decreased from 15.00 Cr. (Sep 2024) to ₹14.00 Cr., marking a decrease of 1.00 Cr..
For EPS in Rs, as of Dec 2024, the value is 5.46. The value appears to be declining and may need further review. It has decreased from ₹5.63 (Sep 2024) to 5.46, marking a decrease of ₹0.17.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 7, 2025, 7:22 pm

Metric	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Sales	66	74	84	100	110	161	239	306	336	487	686	696	751
Expenses	57	62	71	86	90	132	196	248	272	401	575	581	614
Operating Profit	9	11	13	14	20	29	43	58	64	87	112	116	137
OPM %	14%	16%	15%	14%	18%	18%	18%	19%	19%	18%	16%	17%	18%
Other Income	0	0	1	0	0	1	1	0	1	1	5	9	11
Interest	4	5	5	5	8	10	12	12	14	19	29	41	44
Depreciation	1	1	1	1	1	2	3	5	7	12	16	20	24
Profit before tax	5	6	8	8	12	18	29	41	44	57	71	64	80
Tax %	23%	41%	37%	39%	33%	39%	28%	30%	29%	22%	30%	31%
Net Profit	4	4	5	5	8	11	21	29	31	45	50	44	59
EPS in Rs	9.13	8.09	11.31	2.59	3.88	5.34	10.48	12.33	13.47	17.93	20.07	16.70	22.51
Dividend Payout %	22%	25%	18%	77%	26%	19%	14%	16%	17%	15%	15%	18%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2013-2014	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024
YoY Net Profit Growth (%)	0.00%	25.00%	0.00%	60.00%	37.50%	90.91%	38.10%	6.90%	45.16%	11.11%	-12.00%
Change in YoY Net Profit Growth (%)	0.00%	25.00%	-25.00%	60.00%	-22.50%	53.41%	-52.81%	-31.20%	38.26%	-34.05%	-23.11%

Neogen Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:	25%
5 Years:	24%
3 Years:	27%
TTM:	6%

Compounded Profit Growth
10 Years:	28%
5 Years:	16%
3 Years:	12%
TTM:	60%

Stock Price CAGR
10 Years:	%
5 Years:	32%
3 Years:	-3%
1 Year:	23%

Return on Equity
10 Years:	13%
5 Years:	12%
3 Years:	10%
Last Year:	7%

Last Updated: Unknown

Balance Sheet

Last Updated: February 12, 2025, 3:11 pm

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	4	4	4	20	20	20	20	23	23	25	25	26	26
Reserves	12	15	19	8	22	31	50	133	160	414	458	739	759
Borrowings	21	25	24	26	69	82	120	137	222	229	370	389	471
Other Liabilities	16	18	21	27	41	48	56	61	87	131	202	224	218
Total Liabilities	55	63	69	80	152	181	247	355	492	800	1,054	1,378	1,474
Fixed Assets	13	14	13	17	56	67	83	111	127	285	347	345	362
CWIP	0	0	0	1	1	1	0	3	115	11	36	56	27
Investments	0	0	0	0	0	0	0	0	0	81	77	25	212
Other Assets	42	49	55	62	94	112	163	242	250	423	594	952	873
Total Assets	55	63	69	80	152	181	247	355	492	800	1,054	1,378	1,474

Below is a detailed analysis of the balance sheet data for Neogen Chemicals Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

For Equity Capital, as of Sep 2024, the value is ₹26.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹26.00 Cr..
For Reserves, as of Sep 2024, the value is ₹759.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹739.00 Cr. (Mar 2024) to ₹759.00 Cr., marking an increase of 20.00 Cr..
For Borrowings, as of Sep 2024, the value is ₹471.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from ₹389.00 Cr. (Mar 2024) to ₹471.00 Cr., marking an increase of 82.00 Cr..
For Other Liabilities, as of Sep 2024, the value is ₹218.00 Cr.. The value appears to be improving (decreasing). It has decreased from ₹224.00 Cr. (Mar 2024) to ₹218.00 Cr., marking a decrease of 6.00 Cr..
For Total Liabilities, as of Sep 2024, the value is ₹1,474.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹1,378.00 Cr. (Mar 2024) to ₹1,474.00 Cr., marking an increase of 96.00 Cr..
For Fixed Assets, as of Sep 2024, the value is ₹362.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹345.00 Cr. (Mar 2024) to ₹362.00 Cr., marking an increase of 17.00 Cr..
For CWIP, as of Sep 2024, the value is ₹27.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹56.00 Cr. (Mar 2024) to ₹27.00 Cr., marking a decrease of 29.00 Cr..
For Investments, as of Sep 2024, the value is ₹212.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹25.00 Cr. (Mar 2024) to ₹212.00 Cr., marking an increase of 187.00 Cr..
For Other Assets, as of Sep 2024, the value is ₹873.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹952.00 Cr. (Mar 2024) to ₹873.00 Cr., marking a decrease of 79.00 Cr..
For Total Assets, as of Sep 2024, the value is ₹1,474.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹1,378.00 Cr. (Mar 2024) to ₹1,474.00 Cr., marking an increase of 96.00 Cr..

Notably, the Reserves (₹759.00 Cr.) exceed the Borrowings (471.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Cash from Operating Activity +	0	3	9	9	0	12	-4	-34	83	1	-30	-115
Cash from Investing Activity +	0	-1	-2	-4	-33	-13	-20	-29	-134	-146	-94	-122
Cash from Financing Activity +	0	-2	-6	-4	33	-0	24	62	51	188	100	217
Net Cash Flow	0	0	1	0	1	-1	0	-1	-0	44	-25	-20

Free Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Free Cash Flow	-12.00	-14.00	-11.00	-12.00	-49.00	-53.00	-77.00	-79.00	-158.00	-142.00	-258.00	-273.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	67	82	78	58	107	94	93	90	85	82	94	140
Inventory Days	187	173	178	190	228	192	188	257	211	258	275	343
Days Payable	124	117	120	130	177	141	111	71	122	131	147	129
Cash Conversion Cycle	130	138	136	117	158	145	169	276	174	209	223	355
Working Capital Days	132	140	140	126	167	142	163	217	164	190	205	319
ROCE %	26%	26%	27%	26%	23%	23%	26%	22%	17%	14%	13%	10%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Promoters	60.19%	60.19%	60.19%	60.19%	60.18%	60.18%	60.18%	56.89%	56.89%	56.89%	51.22%	51.22%
FIIs	4.36%	4.28%	3.74%	3.99%	4.13%	4.30%	4.25%	4.51%	4.56%	4.65%	8.17%	7.73%
DIIs	18.64%	19.33%	19.12%	18.89%	20.01%	19.87%	20.25%	22.85%	22.14%	22.54%	22.48%	22.52%
Public	16.81%	16.20%	16.96%	16.93%	15.68%	15.63%	15.32%	15.75%	16.42%	15.93%	18.12%	18.51%
No. of Shareholders	39,626	38,642	40,926	49,488	51,686	47,581	45,300	47,018	48,356	46,698	46,470	47,651

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund Name	No of Shares	AUM (%)	Amount Invested (Cr)	Previous Number of Shares	Previous Date	Percentage Change
Axis Small Cap Fund	1,217,809	1.03	183.91	808,141	2025-03-10	50.69%
SBI Large & Midcap Fund	935,051	0.81	139.66	808,141	2025-03-10	15.7%
SBI Contra Fund	808,141	0.64	120.83	808,141	2025-03-10	0%
Quant Small Cap Fund	427,577	0.58	64.57	808,141	2025-03-10	-47.09%
Sundaram Small Cap Fund	265,529	1.39	40.1	808,141	2025-03-10	-67.14%
Axis Flexi Cap Fund	212,801	0.29	32.14	808,141	2025-03-10	-73.67%
SBI Equity Savings Fund	212,711	0.98	31.78	808,141	2025-03-10	-73.68%
Tata ELSS Tax Saver Fund	199,536	0.81	30.13	808,141	2025-03-10	-75.31%
Axis Special Situations Fund	160,897	1.97	24.3	808,141	2025-03-10	-80.09%
Union Small Cap Fund	158,292	1.91	23.91	808,141	2025-03-10	-80.41%

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	13.96	20.03	18.70	13.45	12.28
Diluted EPS (Rs.)	13.96	20.03	18.70	13.45	12.28
Cash EPS (Rs.)	22.11	26.49	22.58	16.38	14.53
Book Value[Excl.RevalReserv]/Share (Rs.)	288.21	193.47	176.12	78.43	66.96
Book Value[Incl.RevalReserv]/Share (Rs.)	288.21	193.47	176.12	78.43	66.96
Revenue From Operations / Share (Rs.)	261.82	275.13	195.37	144.17	131.19
PBDIT / Share (Rs.)	44.55	46.54	35.22	27.81	24.97
PBIT / Share (Rs.)	35.88	40.04	30.53	24.85	22.72
PBT / Share (Rs.)	19.93	28.44	22.88	18.95	17.61
Net Profit / Share (Rs.)	13.45	20.00	17.89	13.43	12.28
NP After MI And SOA / Share (Rs.)	13.51	20.04	17.89	13.43	12.28
PBDIT Margin (%)	17.01	16.91	18.02	19.28	19.03
PBIT Margin (%)	13.70	14.55	15.62	17.23	17.32
PBT Margin (%)	7.61	10.33	11.71	13.14	13.42
Net Profit Margin (%)	5.13	7.26	9.15	9.31	9.36
NP After MI And SOA Margin (%)	5.16	7.28	9.15	9.31	9.36
Return on Networth / Equity (%)	4.68	10.35	10.16	17.11	18.34
Return on Capital Employeed (%)	10.12	15.50	13.10	18.23	25.86
Return On Assets (%)	2.43	4.74	5.58	6.36	8.07
Long Term Debt / Equity (X)	0.16	0.26	0.27	0.63	0.19
Total Debt / Equity (X)	0.51	0.75	0.45	1.10	0.84
Asset Turnover Ratio (%)	0.54	0.74	0.75	0.79	1.02
Current Ratio (X)	1.49	1.60	2.26	1.38	1.54
Quick Ratio (X)	0.76	0.88	1.37	0.72	0.67
Inventory Turnover Ratio (X)	1.41	1.99	2.23	1.48	2.25
Dividend Payout Ratio (NP) (%)	20.98	13.72	11.76	14.89	12.21
Dividend Payout Ratio (CP) (%)	12.78	10.36	9.32	12.20	10.32
Earning Retention Ratio (%)	79.02	86.28	88.24	85.11	87.79
Cash Earning Retention Ratio (%)	87.22	89.64	90.68	87.80	89.68
Interest Coverage Ratio (X)	2.79	4.01	4.60	4.71	4.89
Interest Coverage Ratio (Post Tax) (X)	1.84	2.72	3.34	3.28	3.40
Enterprise Value (Cr.)	3527.65	3541.31	4504.16	2217.48	950.09
EV / Net Operating Revenue (X)	5.11	5.16	9.24	6.59	3.10
EV / EBITDA (X)	30.02	30.51	51.28	34.18	16.31
MarketCap / Net Operating Revenue (X)	4.56	4.66	8.93	5.99	2.68
Retention Ratios (%)	79.01	86.27	88.23	85.10	87.78
Price / BV (X)	4.14	6.63	9.91	11.02	5.24
Price / Net Operating Revenue (X)	4.56	4.66	8.93	6.00	2.68
EarningsYield	0.01	0.01	0.01	0.01	0.03

After reviewing the key financial ratios for Neogen Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
For Basic EPS (Rs.), as of Mar 24, the value is 13.96. This value is within the healthy range. It has decreased from 20.03 (Mar 23) to 13.96, marking a decrease of 6.07.
For Diluted EPS (Rs.), as of Mar 24, the value is 13.96. This value is within the healthy range. It has decreased from 20.03 (Mar 23) to 13.96, marking a decrease of 6.07.
For Cash EPS (Rs.), as of Mar 24, the value is 22.11. This value is within the healthy range. It has decreased from 26.49 (Mar 23) to 22.11, marking a decrease of 4.38.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 288.21. It has increased from 193.47 (Mar 23) to 288.21, marking an increase of 94.74.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 288.21. It has increased from 193.47 (Mar 23) to 288.21, marking an increase of 94.74.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 261.82. It has decreased from 275.13 (Mar 23) to 261.82, marking a decrease of 13.31.
For PBDIT / Share (Rs.), as of Mar 24, the value is 44.55. This value is within the healthy range. It has decreased from 46.54 (Mar 23) to 44.55, marking a decrease of 1.99.
For PBIT / Share (Rs.), as of Mar 24, the value is 35.88. This value is within the healthy range. It has decreased from 40.04 (Mar 23) to 35.88, marking a decrease of 4.16.
For PBT / Share (Rs.), as of Mar 24, the value is 19.93. This value is within the healthy range. It has decreased from 28.44 (Mar 23) to 19.93, marking a decrease of 8.51.
For Net Profit / Share (Rs.), as of Mar 24, the value is 13.45. This value is within the healthy range. It has decreased from 20.00 (Mar 23) to 13.45, marking a decrease of 6.55.
For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 13.51. This value is within the healthy range. It has decreased from 20.04 (Mar 23) to 13.51, marking a decrease of 6.53.
For PBDIT Margin (%), as of Mar 24, the value is 17.01. This value is within the healthy range. It has increased from 16.91 (Mar 23) to 17.01, marking an increase of 0.10.
For PBIT Margin (%), as of Mar 24, the value is 13.70. This value is within the healthy range. It has decreased from 14.55 (Mar 23) to 13.70, marking a decrease of 0.85.
For PBT Margin (%), as of Mar 24, the value is 7.61. This value is below the healthy minimum of 10. It has decreased from 10.33 (Mar 23) to 7.61, marking a decrease of 2.72.
For Net Profit Margin (%), as of Mar 24, the value is 5.13. This value is within the healthy range. It has decreased from 7.26 (Mar 23) to 5.13, marking a decrease of 2.13.
For NP After MI And SOA Margin (%), as of Mar 24, the value is 5.16. This value is below the healthy minimum of 8. It has decreased from 7.28 (Mar 23) to 5.16, marking a decrease of 2.12.
For Return on Networth / Equity (%), as of Mar 24, the value is 4.68. This value is below the healthy minimum of 15. It has decreased from 10.35 (Mar 23) to 4.68, marking a decrease of 5.67.
For Return on Capital Employeed (%), as of Mar 24, the value is 10.12. This value is within the healthy range. It has decreased from 15.50 (Mar 23) to 10.12, marking a decrease of 5.38.
For Return On Assets (%), as of Mar 24, the value is 2.43. This value is below the healthy minimum of 5. It has decreased from 4.74 (Mar 23) to 2.43, marking a decrease of 2.31.
For Long Term Debt / Equity (X), as of Mar 24, the value is 0.16. This value is below the healthy minimum of 0.2. It has decreased from 0.26 (Mar 23) to 0.16, marking a decrease of 0.10.
For Total Debt / Equity (X), as of Mar 24, the value is 0.51. This value is within the healthy range. It has decreased from 0.75 (Mar 23) to 0.51, marking a decrease of 0.24.
For Asset Turnover Ratio (%), as of Mar 24, the value is 0.54. It has decreased from 0.74 (Mar 23) to 0.54, marking a decrease of 0.20.
For Current Ratio (X), as of Mar 24, the value is 1.49. This value is below the healthy minimum of 1.5. It has decreased from 1.60 (Mar 23) to 1.49, marking a decrease of 0.11.
For Quick Ratio (X), as of Mar 24, the value is 0.76. This value is below the healthy minimum of 1. It has decreased from 0.88 (Mar 23) to 0.76, marking a decrease of 0.12.
For Inventory Turnover Ratio (X), as of Mar 24, the value is 1.41. This value is below the healthy minimum of 4. It has decreased from 1.99 (Mar 23) to 1.41, marking a decrease of 0.58.
For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 20.98. This value is within the healthy range. It has increased from 13.72 (Mar 23) to 20.98, marking an increase of 7.26.
For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 12.78. This value is below the healthy minimum of 20. It has increased from 10.36 (Mar 23) to 12.78, marking an increase of 2.42.
For Earning Retention Ratio (%), as of Mar 24, the value is 79.02. This value exceeds the healthy maximum of 70. It has decreased from 86.28 (Mar 23) to 79.02, marking a decrease of 7.26.
For Cash Earning Retention Ratio (%), as of Mar 24, the value is 87.22. This value exceeds the healthy maximum of 70. It has decreased from 89.64 (Mar 23) to 87.22, marking a decrease of 2.42.
For Interest Coverage Ratio (X), as of Mar 24, the value is 2.79. This value is below the healthy minimum of 3. It has decreased from 4.01 (Mar 23) to 2.79, marking a decrease of 1.22.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 1.84. This value is below the healthy minimum of 3. It has decreased from 2.72 (Mar 23) to 1.84, marking a decrease of 0.88.
For Enterprise Value (Cr.), as of Mar 24, the value is 3,527.65. It has decreased from 3,541.31 (Mar 23) to 3,527.65, marking a decrease of 13.66.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 5.11. This value exceeds the healthy maximum of 3. It has decreased from 5.16 (Mar 23) to 5.11, marking a decrease of 0.05.
For EV / EBITDA (X), as of Mar 24, the value is 30.02. This value exceeds the healthy maximum of 15. It has decreased from 30.51 (Mar 23) to 30.02, marking a decrease of 0.49.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 4.56. This value exceeds the healthy maximum of 3. It has decreased from 4.66 (Mar 23) to 4.56, marking a decrease of 0.10.
For Retention Ratios (%), as of Mar 24, the value is 79.01. This value exceeds the healthy maximum of 70. It has decreased from 86.27 (Mar 23) to 79.01, marking a decrease of 7.26.
For Price / BV (X), as of Mar 24, the value is 4.14. This value exceeds the healthy maximum of 3. It has decreased from 6.63 (Mar 23) to 4.14, marking a decrease of 2.49.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 4.56. This value exceeds the healthy maximum of 3. It has decreased from 4.66 (Mar 23) to 4.56, marking a decrease of 0.10.
For EarningsYield, as of Mar 24, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 23) which recorded 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Neogen Chemicals Ltd as of March 12, 2025 is: ₹1,349.65

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of March 12, 2025, Neogen Chemicals Ltd is Overvalued by 25.19% compared to the current share price 1,804.00

Intrinsic Value of Neogen Chemicals Ltd as of March 12, 2025 is: 1,495.63

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of March 12, 2025, Neogen Chemicals Ltd is Overvalued by 17.09% compared to the current share price 1,804.00

Last 5 Year EPS CAGR: 10.82%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a high average ROCE of 21.08%, which is a positive sign. The company has higher reserves (216.92 cr) compared to borrowings (168.08 cr), indicating strong financial stability. The company has shown consistent growth in sales (315.08 cr) and profit (34.08 cr) over the years.	The stock has a high average Working Capital Days of 175.42, which may not be favorable. The stock has a high average Cash Conversion Cycle of 185.83, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Neogen Chemicals Ltd:
1. Net Profit Margin: 5.13%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 10.12% (Industry Average ROCE: 13.99%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 4.68% (Industry Average ROE: 10.73%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 1.84
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 0.76
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 80.1 (Industry average Stock P/E: 47.54)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.51
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Neogen Chemicals Ltd. is a Public Limited Listed company incorporated on 07/03/1989 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24200MH1989PLC050919 and registration number is 050919. Currently Company is involved in the business activities of Manufacture of organic and inorganic chemical compounds. Company's Total Operating Revenue is Rs. 696.36 Cr. and Equity Capital is Rs. 26.38 Cr. for the Year ended 31/03/2024.

INDUSTRY	ADDRESS	CONTACT
Chemicals - Speciality - Others	No. 1002, 10th Floor, Thane Maharashtra 400601	investor@neogenchem.com http://www.neogenchem.com

Management
Name	Position Held
Mr. Haridas Kanani	Chairman & Managing Director
Dr. Harin Kanani	Managing Director
Mr. Shyamsunder Upadhyay	Whole Time Director
Mr. Anurag Surana	Non Exe.Non Ind.Director
Mr. Sanjay Mehta	Independent Director
Mr. Hitesh Reshamwala	Independent Director
Prof. Ranjan Kumar Malik	Independent Director
Mrs. Avi Sabavala	Independent Director

FAQ

What is the latest intrinsic value of Neogen Chemicals Ltd?

The latest intrinsic value of Neogen Chemicals Ltd as on 12 March 2025 is ₹1349.65, which is 25.19% lower than the current market price of 1,804.00, indicating the stock is overvalued by 25.19%. The intrinsic value of Neogen Chemicals Ltd is calculated using PE ratio method. The stock has a market capitalization of ₹4,758 Cr. and recorded a high/low of ₹2,420/1,149 during the current fiscal year 2024-2025. As of Sep 2024, the company has reserves of ₹759 Cr and total liabilities of ₹1,474 Cr.

What is the Market Cap of Neogen Chemicals Ltd?

The Market Cap of Neogen Chemicals Ltd is 4,758 Cr..

What is the current Stock Price of Neogen Chemicals Ltd as on 12 March 2025?

The current stock price of Neogen Chemicals Ltd as on 12 March 2025 is ₹1,804.

What is the High / Low of Neogen Chemicals Ltd stocks in FY 2024-2025?

In FY 2024-2025, the High / Low of Neogen Chemicals Ltd stocks is ₹2,420/1,149.

What is the Stock P/E of Neogen Chemicals Ltd?

The Stock P/E of Neogen Chemicals Ltd is 80.1.

What is the Book Value of Neogen Chemicals Ltd?

The Book Value of Neogen Chemicals Ltd is 298.

What is the Dividend Yield of Neogen Chemicals Ltd?

The Dividend Yield of Neogen Chemicals Ltd is 0.11 %.

What is the ROCE of Neogen Chemicals Ltd?

The ROCE of Neogen Chemicals Ltd is 10.4 %.

What is the ROE of Neogen Chemicals Ltd?

The ROE of Neogen Chemicals Ltd is 7.06 %.

What is the Face Value of Neogen Chemicals Ltd?

The Face Value of Neogen Chemicals Ltd is 10.0.